Heron Therapeutics Inc. (HRTX) Has Jumped To A New High On FDA Designation
Heron Therapeutics Inc. (HRTX) announced Thursday morning that it has received Breakthrough Therapy designation from the FDA for HTX-011, for postoperative pain management.
Source: RTTNews